Skip to content

The study of iFR guided percutaneous coronary intervention on the prognosis of coronary heart disease patients undergoing maintenance dialysis

The study of iFR guided percutaneous coronary intervention on the prognosis of coronary heart disease patients undergoing maintenance dialysis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020708
Enrollment
Unknown
Registered
2019-01-14
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease chronic renal failure

Interventions

intervention group:iFR guided PCI
control group:CAG guided PCI

Sponsors

The Fifth Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with maintenance dialysis end-stage nephropathy aged 18 years or older; 2. Having a history of angina pectoris (CCS II-IV) with positive ischemic heart diseasepositive function test or asymptomatic evidence of myocardial ischemia in the primary blood vessel; 3. Coronary angiography showed that the stenosis of single or multiple vessels including the anterior descending branch and the right circumflex branch (the main branch whose diameter must be greater than 2.25mm) was more than 50%, and at least one lesion requiring PCI was determined by two independent interventional surgeons; 4. SYNTAX score was greater than 32, but the patient had signed and refused to undergo coronary artery bypass surgery; 5. The patient has signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Acute ST-elevation myocardial infarction or acute non-ST-elevation myocardial infarction within 6 days prior to coronary angiography; (2) Women during pregnancy; (3) Chronic complete occlusion, severe distortion or calcification of the coronary arteries,other technical reasons may affect the feasibility or accuracy of iFR testing; (4) Severe concomitant disease and life expectancy < 3 years; (5) previous coronary artery bypass grafting; (6) Contraindication of drug-eluting stents; (7)Hemodynamic instability or cardiogenic shock; (8) Unable to obtain informed consent; (9) Suspicious or definite left main artery lesion; (10) Preoperative diagnosis of active gastrointestinal bleeding,other contraindications to dual antiplatelet drugs,allergy or contraindication to heparin, contrast agent or stainless steel; (11) Participated in other interventional clinical trials (as subjects) in the past 3 months.

Design outcomes

Primary

MeasureTime frame
death;myocardial infarction;revascularization;

Secondary

MeasureTime frame
Number of lesions requiring coronary intervention;Radiation exposure time;Contrast dose;length of stay hospital;complications;operative successful rate;NYHA;CCS;The number of anti-angina drugs;

Countries

China

Contacts

Public ContactJian Chen

The Fifth Affiliated Hospital of Sun Yat-Sen University

drchenj@126.com+86 13926931713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026